Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the average ambulance waiting times in Barnsley Metropolitan Borough Council.
Answered by Maria Caulfield
No specific assessment has been made, as ambulance waiting times are collected at regional ambulance trust level.
Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has to procure Evusheld for the purposes of prescribing to clinically vulnerable patients for protection against covid-19.
Answered by Maggie Throup
The Department is conducting an assessment of Evusheld, including requesting advice from clinicians on the most appropriate option for the National Health Service in line with the available data, the public health situation and other treatments available. While we are considering the advice received, we are unable to confirm a specific timetable for any decision.
Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of funding for dementia services in (a) Barnsley Metropolitan Borough Council, (b) South Yorkshire and (c) England.
Answered by Gillian Keegan
No recent assessment has been made. The Care Act 2014 requires local authorities to deliver a wide range of sustainable high-quality care and support services which meet the needs of the local population, including people living with dementia.
Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the prevalence rates for dementia were in (a) Barnsley Metropolitan Borough Council, (b) South Yorkshire and (c) England in each of the last five years.
Answered by Gillian Keegan
The following table shows the prevalence rate in NHS Barnsley Clinical Commissioning Group (CCG), South Yorkshire and Bassetlaw Sustainability and Transformation Partnership (STP) and in England in each of the last five years for which data is available.
| 2020/21 | 2019/20 | 2018/19 | 2017/18 | 2016/17 |
NHS Barnsley CCG | 0.75 | 0.82 | 0.81 | 0.77 | 0.77 |
South Yorkshire and Bassetlaw STP | 0.79 | 0.89 | 0.89 | 0.86 | 0.86 |
England | 0.71 | 0.79 | 0.78 | 0.76 | 0.76 |
Source: NHS Digital, Quality Outcomes Framework
Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent progress he has made on delivering the Government's dementia moonshot commitment.
Answered by Gillian Keegan
We will set out plans for dementia in England for the next 10 years later this year, which will include plans to increase research funding for dementia and deliver a moonshot.
Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has had recent conversations with the National Joint Council on the potential impact of increasing the standard mileage and fuel rates for NHS workers in line with the increased cost of petrol.
Answered by Edward Argar
We have had no recent discussions with the National Joint Council. The reimbursement of travel costs for National Health Service workers is a matter for the NHS Staff Council, the partnership of employers and NHS trades unions. This is addressed in the NHS Terms and Conditions, jointly agreed by employers and the NHS trades unions.
The current rate for staff who use their vehicles to make journeys in the performance of their duties is 56p per mile, which is above HM Revenue and Customs’ approved mileage rate of 45p per mile. This rate reduces after 3,500 miles to 20p per mile. The NHS Terms and Conditions sets out the process for reviewing the rate of reimbursement every six months, which includes reviewing fluctuations in fuel prices.
The NHS Staff Council has recently published a joint statement on mileage, where the Council commits to write to the Department on the scope and the remit to undertake a possible review. The joint statement is available at the following link:
Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to support NHS workers with the rising cost of living.
Answered by Edward Argar
We are giving NHS workers a pay rise this year, on top of 3% last year when pay was frozen in the wider public sector. The independent pay review bodies will make a recommendation on the uplift’s size, incorporating factors including inflation and the economy.
Additionally, many NHS workers will benefit from direct government cost of living support. Millions of households will receive a £400 discount on their energy bills from October. Furthermore, this year’s Spring Statement included a £330 tax cut for millions of workers through the National Insurance contributions threshold increase in July and a 5p cut to fuel duty.
Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people use large volumes of electricity for medical equipment to treat health conditions at home in (a) Barnsley Metropolitan Borough Council, (b) Yorkshire and (c) the UK.
Answered by Maria Caulfield
The information requested is not collected centrally.
Asked by: Dan Jarvis (Labour - Barnsley North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of ending self-isolation rules for people with covid-19 on immune-suppressed transplant recipients' (a) mortality and (b) quality of life.
Answered by Maggie Throup
No specific assessment has been made. However, those who are at higher risk of serious outcomes from COVID-19 may be eligible for antiviral and other therapeutic treatments and a focused vaccination programme. On 1 April 2022, updated guidance for those with immunosuppression was issued and we continue to engage with the relevant patient and stakeholder groups.